Skip to content

HEALTHCARE BRIEFING

Primary Menu
  • Home
  • Medical Research & Innovation
  • AI in Health
  • Healthcare News
  • Digital Health & Technology
  • Pharma & Biotech
  • Press Releases
    • Business Wire
    • PR Newswire
    • Globe Newswire
Light/Dark Button
  • Home
  • Pharma & Biotechnology
  • STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptides

STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptides

admin Posted on 4 days ago

This is STAT’s D.C. Diagnosis newsletter

President Donald Trump in front of a screen showing Democratic senatorial candidate Abdul El-Sayed.Brendan SMIALOWSKI/AFP via Getty Images

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Care to test your knowledge of which fellas Trump thinks are hot? Send news tips and hunks to [email protected] or John_Wilkerson.07 on Signal.

El-Sayed’s clapback

Abdul El-Sayed is the Democratic Senate candidate in Michigan. He’s also “a second-generation immigrant, a federally funded health equity researcher, a former local public health director, and an evangelist for single-payer health care,” according to Anil Oza’s profile.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

Post navigation

Previous: STAT+: HHS green lights six peptides, despite concerns from FDA scientists
Next: Softer surgery volumes, hospital woes dampened UHS’ Q3 earnings
  • Privacy Policy
  • Terms and Conditions
  • About
  • Contact